Variant report
Variant | esv21023 |
---|---|
Chromosome Location | chr9:99846075-99849809 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:24)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:24 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr9:99847027-99847099 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr9:99846704-99847273 | K562 | blood: | n/a | n/a |
3 | CEBPD | chr9:99846796-99847242 | K562 | blood: | n/a | n/a |
4 | CTCF | chr9:99847078-99847276 | K562 | blood: | n/a | n/a |
5 | CTCF | chr9:99846880-99847030 | GM12866 | blood: | n/a | n/a |
6 | CTCF | chr9:99847109-99847227 | K562 | blood: | n/a | n/a |
7 | CTCF | chr9:99847124-99847173 | Hela-S3 | cervix: | n/a | n/a |
8 | CTCF | chr9:99846665-99846746 | GM10248 | blood: | n/a | n/a |
9 | EP300 | chr9:99846741-99847271 | K562 | blood: | n/a | n/a |
10 | GATA1 | chr9:99846616-99847276 | K562 | blood: | n/a | n/a |
11 | GATA2 | chr9:99846837-99847234 | K562 | blood: | n/a | n/a |
12 | IRF1 | chr9:99846699-99847142 | K562 | blood: | n/a | n/a |
13 | JUND | chr9:99846852-99847118 | K562 | blood: | n/a | n/a |
14 | MYC | chr9:99846934-99847186 | K562 | blood: | n/a | n/a |
15 | NFYB | chr9:99846812-99847013 | K562 | blood: | n/a | n/a |
16 | PML | chr9:99846728-99847194 | K562 | blood: | n/a | n/a |
17 | POLR2A | chr9:99846272-99846384 | GM12878 | blood: | n/a | n/a |
18 | RCOR1 | chr9:99846801-99847212 | K562 | blood: | n/a | n/a |
19 | RCOR1 | chr9:99846945-99847138 | K562 | blood: | n/a | n/a |
20 | TAL1 | chr9:99846829-99847230 | K562 | blood: | n/a | n/a |
21 | TBL1XR1 | chr9:99846919-99847186 | K562 | blood: | n/a | n/a |
22 | TBP | chr9:99846806-99846927 | K562 | blood: | n/a | n/a |
23 | TEAD4 | chr9:99846680-99847366 | K562 | blood: | n/a | n/a |
24 | ZMIZ1 | chr9:99847108-99847138 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000228376 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs111936545 | chr9:99846140-99846141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182243553 | chr9:99846156-99846157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149156802 | chr9:99846242-99846243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143292780 | chr9:99846257-99846258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs537925117 | chr9:99846302-99846303 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs556014918 | chr9:99846324-99846325 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs77432635 | chr9:99846348-99846349 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs577539111 | chr9:99846453-99846454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544694828 | chr9:99846458-99846459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558389024 | chr9:99846509-99846510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186888923 | chr9:99846536-99846537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540570802 | chr9:99846543-99846544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561935866 | chr9:99846561-99846562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573404137 | chr9:99846650-99846651 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs529477704 | chr9:99846667-99846668 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs146775351 | chr9:99846683-99846684 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs191780899 | chr9:99846692-99846693 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs184099650 | chr9:99846702-99846703 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs570018322 | chr9:99846716-99846717 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs140555446 | chr9:99846756-99846757 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs566906580 | chr9:99846772-99846773 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs144881149 | chr9:99846856-99846857 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs189929693 | chr9:99846873-99846874 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs193195619 | chr9:99846893-99846894 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs538061529 | chr9:99846901-99846902 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs185544143 | chr9:99846933-99846934 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs370118881 | chr9:99846961-99846962 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs540404721 | chr9:99846973-99846974 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs571263905 | chr9:99846990-99846991 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs538582059 | chr9:99847023-99847024 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs553485841 | chr9:99847078-99847079 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs559039849 | chr9:99847150-99847151 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs571747630 | chr9:99847161-99847162 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs534204591 | chr9:99847167-99847168 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs138774847 | chr9:99847175-99847176 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs577291474 | chr9:99847233-99847234 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs140282058 | chr9:99847253-99847254 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs573865469 | chr9:99847347-99847348 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs544492308 | chr9:99847350-99847351 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs374640736 | chr9:99847379-99847380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544608417 | chr9:99847392-99847393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368577919 | chr9:99847445-99847446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150341078 | chr9:99847464-99847465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138046400 | chr9:99847507-99847508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144774379 | chr9:99847513-99847514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs28803929 | chr9:99847543-99847544 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs4742681 | chr9:99847569-99847570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190672746 | chr9:99847634-99847635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147177118 | chr9:99847635-99847636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111370798 | chr9:99847805-99847806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
overgrowth syndrome | 16570072 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Nicotine dependence | 17160897 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:99843000-99850000 | Weak transcription | Fetal Heart | heart |
2 | chr9:99846400-99846800 | Enhancers | HSMMtube | muscle |
3 | chr9:99846400-99847000 | Enhancers | K562 | blood |
4 | chr9:99846800-99849000 | Weak transcription | HSMMtube | muscle |
5 | chr9:99849000-99849600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr9:99849000-99849600 | Enhancers | HSMMtube | muscle |
7 | chr9:99849000-99850800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr9:99849200-99851600 | Enhancers | HSMM | muscle |
9 | chr9:99849200-99852200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr9:99849400-99850200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr9:99849400-99851600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr9:99849400-99852200 | Enhancers | HMEC | breast |
13 | chr9:99849600-99850000 | Flanking Active TSS | HSMMtube | muscle |
14 | chr9:99849600-99850200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr9:99849600-99850800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
16 | chr9:99849600-99851000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
17 | chr9:99849600-99851400 | Enhancers | NHEK | skin |
18 | chr9:99849600-99851800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
19 | chr9:99849800-99850200 | Enhancers | Placenta | Placenta |
20 | chr9:99849800-99850600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr9:99849800-99850600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |